DWTX
Price:
$6.14
Market Cap:
$11.73M
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is headquart...[Read more]
Industry
Biotechnology
IPO Date
Stock Exchange
NASDAQ
Ticker
DWTX
According to Dogwood Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.78M. This represents a change of -89.52% compared to the average of 17.01M of the last 4 quarters.
The mean historical Enterprise Value of Dogwood Therapeutics, Inc. over the last ten years is 29.57M. The current 1.78M Enterprise Value has changed 502.86% with respect to the historical average. Over the past ten years (40 quarters), DWTX's Enterprise Value was at its highest in in the September 2020 quarter at 85.19M. The Enterprise Value was at its lowest in in the June 2025 quarter at -6339697.05.
Average
29.57M
Median
7.48M
Minimum
-4418448.40
Maximum
84.08M
Discovering the peaks and valleys of Dogwood Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 296.85%
Maximum Annual Enterprise Value = 84.08M
Minimum Annual Increase = -269.37%
Minimum Annual Enterprise Value = -4418448.40
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 3.30M | -55.94% |
| 2023 | 7.48M | -269.37% |
| 2022 | -4418448.40 | -115.45% |
| 2021 | 28.60M | 296.85% |
| 2020 | 7.21M | -91.43% |
| 2019 | 84.08M | 4.16% |
The current Enterprise Value of Dogwood Therapeutics, Inc. (DWTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.12M
5-year avg
8.43M
10-year avg
29.57M
Dogwood Therapeutics, Inc.’s Enterprise Value is less than Imunon, Inc. (1.11B), less than Sensei Biotherapeutics, Inc. (4.78M), less than BioRestorative Therapies, Inc. (7.90M), less than Bolt Biotherapeutics, Inc. (16.02M), less than Traws Pharma, Inc. (4.83M), less than Cocrystal Pharma, Inc. (4.46M), less than Evogene Ltd. (13.66M), greater than Edesa Biotech, Inc. (-471391.00), less than Ernexa Therapeutics Inc. (7.79M), greater than Cellectar Biosciences, Inc. (1.54M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.11B | $10.08M | |
| 4.78M | $13.32M | |
| 7.90M | $9.46M | |
| 16.02M | $10.18M | |
| 4.83M | $11.25M | |
| 4.46M | $10.61M | |
| 13.66M | $9.59M | |
| -471391.00 | $11.89M | |
| 7.79M | $10.28M | |
| 1.54M | $12.13M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dogwood Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Dogwood Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Dogwood Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Dogwood Therapeutics, Inc. (DWTX)?
What is the 3-year average Enterprise Value for Dogwood Therapeutics, Inc. (DWTX)?
What is the 5-year average Enterprise Value for Dogwood Therapeutics, Inc. (DWTX)?
How does the current Enterprise Value for Dogwood Therapeutics, Inc. (DWTX) compare to its historical average?